1. Home
  2. KEY vs DGX Comparison

KEY vs DGX Comparison

Compare KEY & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KeyCorp

KEY

KeyCorp

N/A

Current Price

$21.90

Market Cap

25.0B

Sector

Finance

ML Signal

N/A

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

N/A

Current Price

$243.93

Market Cap

23.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KEY
DGX
Founded
1825
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.0B
23.2B
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
KEY
DGX
Price
$21.90
$243.93
Analyst Decision
Buy
Buy
Analyst Count
15
13
Target Price
$22.90
$214.38
AVG Volume (30 Days)
8.9M
832.7K
Earning Date
04-16-2026
04-21-2026
Dividend Yield
3.78%
1.82%
EPS Growth
575.00
13.78
EPS
0.88
5.08
Revenue
$7,513,000,000.00
$11,035,000,000.00
Revenue This Year
$15.33
$7.53
Revenue Next Year
$6.06
$3.77
P/E Ratio
$24.85
$48.11
Revenue Growth
62.65
11.78
52 Week Low
$16.47
$171.18
52 Week High
$24.07
$245.68

Technical Indicators

Market Signals
Indicator
KEY
DGX
Relative Strength Index (RSI) 36.58 72.61
Support Level $20.48 $191.82
Resistance Level $21.90 N/A
Average True Range (ATR) 0.43 4.47
MACD -0.12 -0.24
Stochastic Oscillator 10.48 82.80

Price Performance

Historical Comparison
KEY
DGX

About KEY KeyCorp

With assets of around $190 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its three largest markets: Ohio, New York, and Washington. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: